SPY313.78-3.27 -1.03%
DIA259.04-3.96 -1.51%
IXIC10,343.89-89.76 -0.86%

NovoCure Q4 Sales $99.2M Beat $95.65M Estimate

NovoCure (NASDAQ:NVCR) reported quarterly sales of $99.2 million which beat the analyst consensus estimate of $95.65 million by 3.71 percent. This is a 42.38 percent increase over sales of $69.674 million the same

Benzinga · -

NovoCure (NASDAQ:NVCR) reported quarterly sales of $99.2 million which beat the analyst consensus estimate of $95.65 million by 3.71 percent. This is a 42.38 percent increase over sales of $69.674 million the same period last year.